
Purchase CD
>>
Screening Europe
View MedChem EuropeDevelopment & Validation of a Universal Assay for
Metalloproteases: Applications to Protein Biochip Screening Technology
Hakim Djaballah, Director, Memorial
Sloan Kettering Cancer Center (MSKCC)
Inhibitors of Protein Kinase D as Antitumour Agents
Tim Hammonds, Head of Biochemistry and HTS, Cancer Research
Technology
Electrical Impedance Measurement of Cell Adhesion and
Cell-Mediated Cytotoxicity
Anker Hansen, Principal Scientist, Novo Nordisk A/S
Using the 7TM BRET2 Assay for 7TM Receptor Compound Screening
Anders Heding, Head of Molecular Screening and Bioanalysis, 7TM
Pharma A/S
Advanced Data Analysis for Hit and Lead Identification in Cell Based
Assay
Stephan Heyse, General Manager, Genedata
LANCE Ultra & SureFire - New Tools to Solve the Kinase Conundrum
Krystyna Hohenauer, Screening Reagents Product Leader Europe,
PerkinElmer Life and Analytical Sciences
High Throughput Imaging with the Open Microscopy Environment
Bernd Jagla, Research Scientist, Columbia University
The Human MAP3 Kinase COT – A Case Study of Assay Development for
High-throughput Screening and Hits Follow-up Characterization
Yong Jia, Senior Scientist, Abbott Laboratories
Screening Image Browser: Database and Tool for the Integration,
Browsing and Analysis of Large Scale Image High-Content Screening Data
Karol Kozak, IT-Specialist, Max Planck Institute of Molecular Cell
Biology and Genetics
A Physiological Approach to GPCR Screening Using a Label-free
Cell-Based Platform
Dave Laughton, Associate Principal Scientist, AstraZeneca
Rapid, Label-Free Screening and Affinity Ranking of Fragment
Libraries Binding Selectively to Drug Targets
Stefan Löfås, VP, Chief Scientific Officer, Biacore International
Automated Assay Development and Optimisation
Lorenz Mayr, Executive Director,
Novartis Pharmaceutical
High Content Screening of Protein Kinases using Microplate
Cytometry
Sarah Payne, Product Manager, TTP LabTech Limited
LanthaScreen™ GFP Cellular Kinase Assays: Biochemical Assays with Biological
Relevance
John Printen, Cell Signaling Business Segment Director,
Invitrogen
Cellular Screening Technologies for G Protein-Coupled Receptors
Hans Pirard, European Technology Manager, PerkinElmer Life and
Analytical Sciences
Microsphere Mediated Sensing and Cellular Delivery
Rosario Sanchez-Martin, Research Fellow, University of
Edinburgh
SPR Screening of Chemical Microarray for Fragment-Based Discovery
Renate Sekul, VP R&D,
Graffinity Pharmaceuticals
Investigation of Drug Interactions with Cation Ttransporters
Using a Solid Supported Membrane
Francesco Tadini, Research Associate, University of Florence
MedChem Europe
View Screening Europe
Lessons Learned in Virtual Screening
Darren Fayne, Senior Research Fellow in
Biochemistry, Trinity College Dublin
Multicomponent Reactions: New Synthetic Opportunities for Privileged
Heterocyclic Cores
Rodolfo Lavilla, Professor of
Chemistry and Molecular Pharmacology, Institute for Research in Biomedicine
Diversity-Oriented Syntheses of Heterocycles Initiated by
Sequentially Transition Metal-Catalysed Processes
Thomas Müller, Professor of
Organic Chemistry, Heinrich-Heine-Universität Düsseldorf
Evolution of Phage Display: From Bioactive Peptides to Bioselective
Nanomaterials
Valery Petrenko, Professor,
Auburn University
Ligand Discovery Using the Virtual Screening Program LIDAEUS
Malcolm Walkinshaw, Professor
of Structural Biochemistry, University of Edinburgh
Multicomponent Reactions and Domino Processes: Powerful Tool for
Generating Molecular Complexity and Diversity
Jieping Zhu, Research
Director, Institut de Chimie des Substances Naturelles CNRS
Round Table Discussion:
Synthesis in Medicinal Chemistry
– Quo Vadis?